Skip to main content

Advertisement

Log in

Lymphocyte immunotherapy in the treatment of recurrent miscarriage: systematic review and meta-analysis

  • Gynecologic Endocrinology and Reproductive Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

Recurrent miscarriage (RM) affects up to 2–3% of couples of reproductive age. There are several causes for this condition, including immunologic. The embryo is considered an allograft, subject to the rejection mechanisms of the maternal immune system. Immunotherapy involving immunization with lymphocytes is considered in cases of idiopathic RM. However, there is still no consensus regarding the efficacy and safety of this therapy.

Methods

This systematic review and meta-analysis evaluated the data available in the literature regarding the efficacy and safety of the use of immunotherapy with lymphocytes in couples with history of RM. Searches in PubMed/Medline, SCOPUS, and Cochrane Library databases were conducted, using the following keywords: “recurrent miscarriage,” “lymphocyte immunotherapy,” and “meta-analysis.” Statistical analyses were performed using Review Manager 5.3 (RevMan), version 5.3.

Results

Six published meta-analysis were retrieved; two found no improvements in the rate of live births after the use of immunization with lymphocytes in the treatment of RM, and four found a beneficial effect of the use of immunotherapy with lymphocytes in cases of RM, with significant improvements in the rate of live births.

Conclusion

Data available in the literature supports the efficacy and safety of immunotherapy with lymphocytes in cases of RM without an identified cause.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Rai R, Regan L (2006) Recurrent miscarriage. Lancet 368:601–611

    Article  PubMed  Google Scholar 

  2. Practice Committee of American Society for Reproductive Medicine (2013) Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril 99:63

    Article  Google Scholar 

  3. Garrido-Gimenez C, Alijotas-Reig J (2015) Recurrent miscarriage: causes, evaluation and management. Postgrad Med J 91:151–162

    Article  PubMed  Google Scholar 

  4. Medawar PD (1953) Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symposium of the Society for Experimental Biology, p 320

  5. Clarke B, Kirby DR (1966) Maintenance of histocompatibility polymorphisms. Nature 211:999–1000

    Article  CAS  PubMed  Google Scholar 

  6. Beer AE, Quebbeman JF, Ayers JW, Haines RF (1981) Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans. Am J Obstet Gynecol 141:987–999

    CAS  PubMed  Google Scholar 

  7. Kwak JY, Gilman-Sachs A, Moretti M, Beaman KD, Beer AE (1998) Natural killer cell cytotoxicity and paternal lymphocyte immunization in women with recurrent spontaneous abortions. Am J Reprod Immunol 40:352–358

    Article  CAS  PubMed  Google Scholar 

  8. Yokoo T, Takakuwa K, Ooki I, Kikuchi A, Tamura M, Tanaka K (2006) Alteration of TH1 and TH2 cells by intracellular cytokine detection in patients with unexplained recurrent abortion before and after immunotherapy with the husband’s mononuclear cells. Fertil Steril 85:1452–1458

    Article  PubMed  Google Scholar 

  9. Zenclussen AC, Gerlof K, Zenclussen ML, Sollwedel A, Bertoja AZ, Ritter T et al (2005) Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+ CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 166:811–822

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kwak-Kim J, Han AR, Gilman-Sachs A, Fishel S, Leong M, Shoham Z (2013) Current trends of reproductive immunology practices inin vitro fertilization (IVF)—a first world survey using IVF-worldwide.com. Am J Reprod Immunol 69:12–20

    Article  CAS  PubMed  Google Scholar 

  11. Taylor C, Faulk WP (1981) Prevention of recurrent spontaneous abortions with leukocyte transfusion. Lancet 2:68–70

    Article  CAS  PubMed  Google Scholar 

  12. Mowbray JF, Gibbons C, Lidell H, Reginald PW, Underwood JL, Beard RW (1985) Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells. Lancet 1:941–943

    Article  CAS  PubMed  Google Scholar 

  13. Khonina NA, Broitman EV, Shevela EY, Pasman NM, Chernykh ER (2013) Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion. Arch Gynecol Obstet 288:933–937

    Article  CAS  PubMed  Google Scholar 

  14. Kheshtchin N, Gharagozloo M, Andalib A, Ghahiri A, Maracy MR, Rezaei A (2010) The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapy. Am J Reprod Immunol 64:104–112

    CAS  PubMed  Google Scholar 

  15. Szpakowski A, Malinowski A, Zeman K, Wilczyński J, Kolasa D, Nowak M et al (2001) The influence of paternal lymphocytes immunization on percentage of peripheral blood CD16+/CD56+ cells in women with primary recurrent spontaneous abortion. Ginekol Pol 72:1063–1068

    CAS  PubMed  Google Scholar 

  16. Wu L, Luo LH, Zhang YX, Li Q, Xu B, Zhou GX et al (2014) Alteration of Th17 and Treg cells in patients with unexplained recurrent spontaneous abortion before and after lymphocyte immunization therapy. Reprod Biol Endocrinol 12:74

    Article  PubMed  PubMed Central  Google Scholar 

  17. Pandey MK, Agrawal S (2004) Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lynphocyte immunization for women with recurrent spontaneous abortion. Int Immunopharmacol 4:289–298

    Article  CAS  PubMed  Google Scholar 

  18. Toshiyuki T (2004) Diagnosis and treatment of recurrent miscarriage associated with immunologic disorders: is paternal lymphocyte immunization a relic of the past. J Nippon Med Sch 71:308–313

    Article  Google Scholar 

  19. Kwak JY, Kwak FM, Gilman-Sachs A, Beaman KD, Cho DD, Beer AE (2000) Immunoglobulin G infusion treatment for women with recurrent spontaneous abortions and elevated CD56+ natural killer cells. Early Pregnancy 4:154–164

    CAS  PubMed  Google Scholar 

  20. Wong LF, Porter TF, Scott JR (2014) Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev (10):CD000112

  21. Opelz G, Sengar DP, Mickey MR, Terasaki PI (1973) Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 5:253–259

    CAS  PubMed  Google Scholar 

  22. Clark DA (2012) The end of evidence-based medicine? Inflammopharmacol 20:187–193

    Article  Google Scholar 

  23. Fraser EJ, Grimes DA, Schultz KF (1993) Immunization as therapy for recurrent spontaneous abortion: a review and metaanalysis. Obstet Gynecol 82:854–859

    CAS  PubMed  Google Scholar 

  24. Collins J, Roberts R (1994) Immunotherapy for recurrent spontaneous abortion: analysis 1. Am J Reprod Immunol 32:275–280

    Article  Google Scholar 

  25. Coulam CB, Clark DA, Collins J, Scott JR (1994) Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 32:55–72

    Article  Google Scholar 

  26. Pandey MK, Thakur S, Agrawal S (2004) Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Arch Gynecol Obstet 269:161–172

    Article  PubMed  Google Scholar 

  27. Liu Z, Xu H, Kang X, Wang T, He L, Zhao A (2016) Allogenic lymphocyte immunotherapy for unexplained recurrent spontaneous abortion: a meta-analysis. Am J Reprod Immunol 76:443–453

    Article  CAS  PubMed  Google Scholar 

  28. Cauchi MN, Lim D, Young DE (1991) Treatment of recurrent aborters by immunization with paternal cells-controlled trial. Am J Reprod Immunol 25:16–17

    Article  CAS  PubMed  Google Scholar 

  29. Ho HN, Thomas HJ, Honjou H (1991) Immunotherapy for recurrent spontaneous abortions in a Chinese population. Am J Reprod Immunol 25:10–15

    Article  CAS  PubMed  Google Scholar 

  30. Clark DA, Daya S (1991) Trials and tribulation in the treatment of recurrent spontaneous abortion. Am J Reprod Immunol 25:18–24

    Article  CAS  PubMed  Google Scholar 

  31. Gatenby PA, Cameron K (1993) Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial. Am J Reprod Immunol 29:88–94

    Article  CAS  PubMed  Google Scholar 

  32. Paul A, Gatenby PA, Helen M (1989) Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: correlates with outcome. Am J Reprod Immunol 19:21–27

    Article  Google Scholar 

  33. Daya S, Joanne G (1994) The effectiveness of allogeneic leukocyte immunization in unexplained primary recurrent spontaneous abortion. Am J Reprod Immunol 32:294–302

    Article  CAS  PubMed  Google Scholar 

  34. Illeni MT, Marelli G, Parazzin F (1994) Immunotherapy and recurrent abortion: a randomized clinical trial. Hum Reprod 9:1247–1249

    CAS  PubMed  Google Scholar 

  35. Christiansen OB, Mathiesen O, Meretehu S (1994) Placebo-controlled trial of active immunization with third party leukocytes in recurrent miscarriage. Acta Obstet Ginecol Scand 73:261–268

    Article  CAS  Google Scholar 

  36. Carp HJ, Toder V, Torchinsky A (1997) Allogenic leukocyte immunization after five or more miscarriages. Hum Reprod 12:250–255

    Article  CAS  PubMed  Google Scholar 

  37. Pandey MK, Halder A, Agarwal S (2003) Immunotherapy in recurrent spontaneous abortion: randomized and non-randomized trials. Internet J Gynecol Obstet 2:13

    Google Scholar 

  38. Hong L, Huaixiu W, Jing W (2003) The lymphocyte injects and treats the habitual abortion that the immune factor causes. Med Mag Shanxi 32:308–309

    Google Scholar 

  39. Yanping C, Xiaoye Z, Qingmei B (2011) Study of immunotherapy with lymphocytes in women with recurrent spontaneous abortion. Mod Prev Med 38:1626–1627

    Google Scholar 

  40. Lin S, Yan S, Shan E (2012) Analysis the efficacy of immunotherapy with lymphocytes for recurrent spontaneous abortion. Jilin Med 33:1822–1823

    Google Scholar 

  41. Aiwu W, Mingzhu L, Runzhi W (2013) Preventive treatment of unexplained recurrent spontaneous abortion and effect on pregnancy outcomes by lymphocytes immunotherapy. China J Chin Med 28:876–878

    Google Scholar 

  42. Bin T, Kaishu H, Wenquan Z (2013) Analysis of lymphocytes immunotherapy for recurrent spontaneous abortion. Chin Med Treat Works 21:171–172

    Google Scholar 

  43. Ober C, Karrison T, Odem RB, Barnes RB, Branch DW, Stephenson MD (1999) Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet 354:365–369

    Article  CAS  PubMed  Google Scholar 

  44. Clark DA (2009) Cell-surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human recurrent pregnancy loss. Am J Reprod Immunol 61:75–84

    Article  PubMed  Google Scholar 

  45. Yu HL, Deng XH, Chao L, Chen C, Han YL (2013) Study on positive rate of blocking antibody in women with recurrent spontaneous abortion administered by route and frequency of paternal lymphocyte immunotherapy. Zhonghua Fu Chan Ke Za Zhi 48:903–906

    PubMed  Google Scholar 

  46. Khonina NA, Broitman EV, Shevela EY, Pasman NM, Chernykh ER (2013) Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion. Arch Gynecol Obstet 288:933–937

    Article  CAS  PubMed  Google Scholar 

  47. Liang P, Mo M, Li GG, Yin B, Cai J, Wu T et al (2012) Comprehensive analysis of peripheral blood lymphocytes in 76 women with recurrent miscarriage before and after lymphocyte immunotherapy. Am J Reprod Immunol 68:164–174

    Article  CAS  PubMed  Google Scholar 

  48. Gharesi-Fard B, Zolghadri J, Haghbin H (2013) Soluble CD30 (sCD30) and effectiveness of leukocyte therapy in recurrent pregnancy loss patients. J Reprod Immunol 97:240–244

    Article  CAS  PubMed  Google Scholar 

  49. Kling C, Steinmann J, Westphal E, Magez J, Kabelitz D (2006) Adverse effects of intradermal allogeneic lymphocyte immunotherapy: acute reactions and role of autoimmunity. Hum Reprod 21:429–435

    Article  CAS  PubMed  Google Scholar 

  50. Kling C, Schmutzler A, Wilke G, Hedderich J, Kabelitz D (2008) Two-year outcome after recurrent implantation failure: prognostic factors and additional interventions. Arch Gynecol Obstet 278:135–142

    Article  PubMed  Google Scholar 

  51. Lymphocyte Immune Theraphy (LIT) Letter. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm105848.htm. Accessed 22 Jan 2015

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edward Araujo Júnior.

Ethics declarations

Funding

This study was not funding.

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cavalcante, M.B., Sarno, M., Araujo Júnior, E. et al. Lymphocyte immunotherapy in the treatment of recurrent miscarriage: systematic review and meta-analysis. Arch Gynecol Obstet 295, 511–518 (2017). https://doi.org/10.1007/s00404-016-4270-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-016-4270-z

Keywords

Navigation